Division of Blood Disorders, National Center on Birth Defects and Development Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Semin Perinatol. 2019 Jun;43(4):200-204. doi: 10.1053/j.semperi.2019.03.004. Epub 2019 Mar 9.
In the U.S., deaths due to pulmonary embolism (PE) account for 9.2% of all pregnancy-related deaths or approximately 1.5 deaths per 100,000 live births. Maternal deaths and maternal morbidity due to PE are more common among women who deliver by cesarean section. In the past decade, the clinical community has increasingly adopted venous thromboembolism (VTE) guidelines and thromboprophylaxis recommendations for pregnant women. Although deep vein thrombosis rates have decreased during this time-period, PE rates have remained relatively unchanged in pregnancy hospitalizations and as a cause of maternal mortality. Changes in the health profile of women who become pregnant, particularly due to maternal age and co-morbidities, needs more attention to better understand the impact of VTE risk during pregnancy and the postpartum period.
在美国,肺栓塞(PE)导致的死亡占所有与妊娠相关死亡的 9.2%,即每 10 万例活产中约有 1.5 例死亡。剖宫产分娩的女性中,PE 导致的孕产妇死亡和发病率更高。在过去十年中,临床医生越来越多地采用静脉血栓栓塞(VTE)指南和妊娠女性的血栓预防建议。尽管在此期间深静脉血栓形成的发生率有所下降,但妊娠住院期间和孕产妇死亡的原因中,PE 的发生率仍相对不变。由于孕产妇年龄和合并症等因素导致的孕妇健康状况的变化,需要更多关注,以更好地了解妊娠和产后期间 VTE 风险的影响。